Bank of America Securities analyst Joanna Gajuk reiterated a Sell rating on Aveanna Healthcare Holdings (AVAH – Research Report) yesterday and set a price target of $1.10. The company’s shares closed yesterday at $1.82.
According to TipRanks, Gajuk is a 3-star analyst with an average return of 3.6% and a 56.00% success rate. Gajuk covers the Healthcare sector, focusing on stocks such as Option Care Health, Addus Homecare, and US Physical Therapy.
Currently, the analyst consensus on Aveanna Healthcare Holdings is a Moderate Sell with an average price target of $1.41.
See the top stocks recommended by analysts >>
The company has a one-year high of $2.20 and a one-year low of $0.67. Currently, Aveanna Healthcare Holdings has an average volume of 173.4K.
Based on the recent corporate insider activity of 10 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of AVAH in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aveanna Healthcare Holdings Inc is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. It directly address the most pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home, the lower cost care setting preferred by patients.
Read More on AVAH:
- Aveanna Healthcare Holdings Announces Second Quarter 2023 Financial Results
- Aveanna Healthcare Holdings Announces Agreement to Extend its $175 Million Securitization Facility
- Aveanna announces agreement to extend $175M securitization facility
- Aveanna Announces Second Quarter 2023 Earnings Release Date and Conference Call
- Aveanna price target raised to $1.70 from $1.40 at Truist
